Judged: two independent readers; copy check clear.
V
V In this source, V refers to the label for a specific arm of the MATCH phase II clinical trial.
In this source, V refers to the label for a specific arm of the MATCH phase II clinical trial. It identifies the study group testing sunitinib in patients whose tumors have KIT gene mutations, excluding gastrointestinal stromal tumors, renal cell cancers, and pancreatic neuroendocrine tumors.